---
title: "Merck — Stuff That Spins"
description: "Narrative intelligence for Merck: 1 tracked articles, claims, and spin patterns across AI and technology coverage."
	canonical: "https://stuffthatspins.com/entities/merck"
html: "https://stuffthatspins.com/entities/merck"
json: "https://stuffthatspins.com/entities/merck.json"
markdown: "https://stuffthatspins.com/entities/merck.md"
keywords: ["Merck", "company", "AI", "technology", "spin analysis"]
json_ld: |
  {"@context":"https://schema.org","@graph":[{"@type":"Organization","@id":"https://stuffthatspins.com/entities/merck","name":"Merck","description":"Narrative intelligence for Merck across AI and technology coverage.","url":"https://stuffthatspins.com/entities/merck","identifier":"merck"},{"@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"Stuff That Spins","item":"https://stuffthatspins.com/"},{"@type":"ListItem","position":2,"name":"Merck","item":"https://stuffthatspins.com/entities/merck"}]},{"@type":"ItemList","name":"Articles about Merck","itemListElement":[{"@type":"ListItem","position":1,"url":"https://stuffthatspins.com/spin/moderna-stock-mrna-surges-over-110-after-announcing-the-first-ever-positive-phase-3-results-for-a-personalized-cancer-va","name":"Moderna stock, $MRNA , surges over +110% after announcing the first ever positive Phase 3 results for a personalized cancer vaccine."}]},{"@type":"ItemList","name":"Claims involving Merck","itemListElement":[{"@type":"ListItem","position":1,"item":{"@type":"Claim","text":"Moderna and Merck said their personalized cancer vaccine helped cut the recurrence of melanoma in a large, late-stage trial."}}]}]}
---

# Merck

**Type:** company  
## Related Articles

- [Moderna stock, $MRNA , surges over +110% after announcing the first ever positive Phase 3 results for a personalized cancer vaccine.](https://stuffthatspins.com/spin/moderna-stock-mrna-surges-over-110-after-announcing-the-first-ever-positive-phase-3-results-for-a-personalized-cancer-va) — August 19, 2026

## Related Claims

- Moderna and Merck said their personalized cancer vaccine helped cut the recurrence of melanoma in a large, late-stage trial.

---
*HTML version: https://stuffthatspins.com/entities/merck*